WHO ICTRP trial

A Phase II Multicentre Study of perioperative Chemotherapy for resectable…

EUCTR2008-007546-56-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2008-007546-56-DE
Public title A Phase II Multicentre Study of perioperative Chemotherapy for resectable Adenocarcinoma of the Gastroesophageal Junction and of the Stomach
Scientific title A Phase II Multicentre Study of perioperative Chemotherapy for resectable Adenocarcinoma of the Gastroesophageal Junction and of the Stomach
Primary sponsor Klinikum der Universität München, Campus Großhadern
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Germany
Conditions Resectable Adenokarcinoma of the Gastroesophageal Junction and of the Stomach MedDRA version: 13.1 Level: LLT Classification code 10017768 Term: Gastric cancer stage IV without metastases System Organ Class: 10029104 - Neoplasms benign…
Interventions Trade Name: Taxotere 20 mg Product Name: Docetaxel Product Code: Docetaxel Pharmaceutical Form: Concentrate and solvent for solution for injection INN or Proposed INN: DOCETAXEL CAS Number: 114977-28-5 Current Sponsor code: Docetaxel…
Registration date Aug 21, 2009
Secondary IDs NEO-FLOT
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations